A股異動 | 妙可藍多(600882.SH)復牌漲停 內蒙蒙牛將成公司控股股東
格隆匯12月14日丨妙可藍多(600882.SH)今日復牌漲停,封單逾6萬手,現報43.09元,暫成交870萬元,最新總市值176億元。妙可藍多公佈,公司擬與內蒙蒙牛簽署股份認購協議,公司擬非公開發行股票募集資金總額不超過300,000萬元,發行數量不超過100,976,102股,收購人以現金方式認購公司非公開發行股票。本次交易完成後,上市公司的控股股東將變更為內蒙蒙牛;由於內蒙蒙牛的間接控股股東蒙牛乳業為香港上市公司且其股權結構較為分散,因此本次交易完成後,上市公司不存在實際控制人。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.